Cargando…
The rapid and highly parallel identification of antibodies with defined biological activities by SLISY
The therapeutic applications of antibodies are manifold and the emergence of SARS-CoV-2 provides a cogent example of the value of rapidly identifying biologically active antibodies. We describe an approach called SLISY (Sequencing-Linked ImmunoSorbent assaY) that in a single experiment can assess th...
Autores principales: | Lu, Steve, Mattox, Austin K., Aitana Azurmendi, P., Christodoulou, Ilias, Wright, Katharine M., Popoli, Maria, Chen, Zan, Sur, Surojit, Li, Yana, Bonifant, Challice L., Bettegowda, Chetan, Papadopoulos, Nickolas, Zhou, Shibin, Gabelli, Sandra B., Vogelstein, Bert, Kinzler, Kenneth W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9808734/ https://www.ncbi.nlm.nih.gov/pubmed/36596784 http://dx.doi.org/10.1038/s41467-022-35668-6 |
Ejemplares similares
-
An isogenic cell line panel for sequence-based screening of targeted anticancer drugs
por: Cook, Ashley L., et al.
Publicado: (2022) -
Structural engineering of chimeric antigen receptors targeting HLA-restricted neoantigens
por: Hwang, Michael S., et al.
Publicado: (2021) -
Hydrophobic interactions dominate the recognition of a KRAS G12V neoantigen
por: Wright, Katharine M., et al.
Publicado: (2023) -
FAST-SeqS: A Simple and Efficient Method for the Detection of Aneuploidy by Massively Parallel Sequencing
por: Kinde, Isaac, et al.
Publicado: (2012) -
An engineered antibody fragment targeting mutant β-catenin via major histocompatibility complex I neoantigen presentation
por: Miller, Michelle S., et al.
Publicado: (2019)